Navigation Links
UCLA study suggests link between untreated depression, response to shingles vaccine
Date:2/19/2013

Can an individual's state of mind effect how well a vaccine may work? In the case of seniors and shingles, the answer is yes.

Reporting in the current online edition of the journal Clinical Infectious Diseases, Dr. Michael Irwin, a professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA, demonstrates a link between untreated depression in older adults and decreased effectiveness of the herpes zoster or shingles vaccine.

Shingles is a painful, blistering skin rash that can last for months or even years. It's caused by the varicellazoster virus, the same virus that causes chickenpox. It's thought to strike more than a million people over the age of 60 each year in the U.S.

Every year, health officials urge individuals 50 and older to get vaccinated against the virus. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition.

But in a two-year study, Irwin, the first author of the research and director of the UCLA Cousins Center for Psychoneuroimmunology, and his colleagues measured immune responses to the shingles vaccination among 40 people aged 60 or older who suffered from a major depressive disorder and compared these responses to similar levels in 52 control patients matched by age and gender. Measurements were taken at the beginning of the study, and then at six weeks, one year and two years after the patients received either the shingles vaccine or a placebo.

Depressed patients not being treated with antidepressants showed a weaker immune response to the varicellazoster virus and thus were less able to respond to the shingles vaccine than patients who were not depressed and patients who suffered from depression but werereceiving treatment with antidepressants.

The findings suggest that patients with untreated depression were "poorly protected by the shingles vaccination," Irwin said.


'/>"/>
Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study shows reduced risk of preterm birth for pregnant women vaccinated during pandemic flu
2. Too Much Coffee in Pregnancy Tied to Smaller, Later Newborns, Study Says
3. Early Exposure to Gluten May Help Babies Avoid Celiac Risk: Study
4. CWRU study examines family struggles with anger and forgiveness when relative is dying
5. Emerging SARS-Like Virus Well-Suited to Attack Humans: Study
6. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
7. A New Study by CogniFit Finds That Young Men Have a Strong Cognitive Advantage Over Young Women
8. Baby wash does not damage babys skin barrier function, study finds
9. Study suggests women have higher risk of hip implant failure
10. Study suggests reduced lung function in infancy associated with wheeze later
11. Doctors fail to communicate impact of heart devices with patients, SLU study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
(Date:1/22/2015)... January 22, 2015 Gabe’s Chemo Duck Program is ... the first app ever created for kids with cancer. The Chemo ... and devices, is filled with enjoyable games to help children of ... The free app helps to keep kids entertained, educated and at ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... Osteotech, Inc.,(Nasdaq: OSTE ), a global ... musculoskeletal system, announced today that Sam Owusu-Akyaw,Osteotech,s President ... Albany Capital,s Regenerative Technologies Conference in New York.,Mr. ... Eastern Time on,Tuesday, September 11, 2007. Osteotech, ...
... undergone previous heart surgery, Belgian study finds , , MONDAY, Sept. ... tiny openings significantly reduces the risk of death for people ... "We were astonished that the reduction in risk was much ... staff surgeon at the OLV Clinic in Aalst and lead ...
... Sponsorship will provide support for ADA,s Por Tu Familia ... Association (ADA) today announced that Goya Foods, Inc. has ... outreach program, Por Tu,Familia. Por Tu Familia (or "for ... about the seriousness of diabetes,and the importance of a ...
... NEW YORK, Sept. 10 portionpals(R), the fastest ... reached the quarter million,sales mark with no national ... operation. "Our sales are coming strictly from word-of-mouth," ... September 9th, Jamie Moose,of Manistique, Michigan became our ...
... choices , MONDAY, Sept. 10 (HealthDay News) -- U.S. and ... a comprehensive recommendation on how much of what types of ... diets. , Both the American Dietetic Association and the Dietitians ... that 20 percent to 30 percent of energy needs should ...
... Broad Street, LANSDOWNE, Va., Sept. 10 ... by former Philadelphia,Eagle and now pastor Herbert Lusk, ... Christ to bring the women of Philadelphia much ... targeting an,area of downtown Philadelphia, where there are ...
Cached Medicine News:Health News:Small Incisions Make Heart Valve Surgery Safer 2Health News:Small Incisions Make Heart Valve Surgery Safer 3Health News:American Diabetes Association and Goya Foods Inc. Team Up To Support Diabetes Awareness and Outreach in the Latino Community 2Health News:American Diabetes Association and Goya Foods Inc. Team Up To Support Diabetes Awareness and Outreach in the Latino Community 3Health News:Experts Sort Out Good Fats From Bad 2Health News:Women of Philadelphia Win by a 'Touchdown' 2
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced today ... been enrolled into the Company,s Phase 2 clinical trial. ... of Gem,s lead compound, GPX-150 (an investigational medication), in ... metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)...  BiOptix is pleased to announce the appointment of Dr. ... and Biochemistry. Scott joins the company after previous scientific leadership ... the course of his nearly 20 year career in ... nationally recognized thought leader in the biosensor field and ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... to Eye via,Ophthalmic Artery, WASHINGTON, March 17 ... retinoblastoma -- a,deadly, inherited cancer of one or ... from having their eyes surgically removed (enucleated),according to ... the Society of,Interventional Radiology,s 33rd Annual Scientific Meeting. ...
... investigational regimen demonstrates important role of, radioimmunotherapy in ... ... remissions, SEATTLE, March 17 Cell Therapeutics, ... that patients with previously,untreated follicular non-Hodgkin,s lymphoma (NHL) ...
Cached Medicine Technology:New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases 2New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases 3New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases 4Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin's Lymphoma 2Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin's Lymphoma 3Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin's Lymphoma 4
Standard reading test. 'It was the month of May'...
Standard reading test. "Clearing weather..."...
The PowerLab 4/25T is an integrated data recording unit featuring built-in amplifiers. With appropriate transducers and accessories the PowerLab 4/25T covers the broad experimental requirements in li...
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
Medicine Products: